Abstract
Despite many efforts, the currently available treatments for leishmaniasis are not fully effective. To discover new medications, drug repurposing arises as a promising strategy. We present data that supports the use of the antidepressant clomipramine against Leishmania amazonensis. The drug presented selective activity at micromolar range against both the parasite forms and stimulated nitric oxide production in host macrophages. Regarding the mechanism of action, clomipramine led parasites do mitochondrial depolarization, which coupled with the inhibition of trypanothione reductase induced strong oxidative stress in the parasites. The effects observed in promastigotes included lipoperoxidation, plasma membrane permeabilization, and apoptosis hallmarks (i.e., DNA fragmentation, phosphatidylserine exposure, and cell shrinkage). The mechanism of action in both parasitic forms was quite similar, but amastigotes also exhibited energetic stress, reflected by a reduction of adenosine triphosphate levels. Such differential effects might be attributable to the metabolic particularities of each form of the parasitic. Ultrastructural alterations of the endomembrane system and autophagy were also observed, possibly indicating an adaptive response to oxidative stress. Our results suggest that clomipramine interferes with the redox metabolism of L. amazonensis. In spite of the cellular responses to recover the cellular homeostasis, parasites underwent programmed cell death.
Similar content being viewed by others
References
Andrews KT, Fisher G, Skinner-Adams TS (2014) Drug repurposing and human parasitic protozoan diseases. Int J Parasitol Drugs Drug Resist 4:95–111
Barral A, Pedral-Sampaio D, Grimaldi-Júnior G, Momen H, McMahon-Pratt D, Ribeiro de Jesus A, Almeida R, Badaro R, Barral-Netto M, Carvalho EM (1991) Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 44:536–546
Benson TJ, McKie JH, Garforth J, Borges A, Fairlamb A, Douglas KT (1992) Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures. Biochem J 286:9–11
Berman JD, Dwyer DM, Wyler DJ (1979) Multiplication of Leishmania in human macrophages in vitro. Infect Immun 26:375–379
Blommaart EF, Krause U, Schellens JP, Vreeling-Sindelárová H, Meijer AJ (1997) The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur J Biochem 243:240–246
Bringaud F, Rivière L, Coustou V (2006) Energy metabolism of trypanosomatids: adaptation to available carbon sources. Mol Biochem Parasitol 149:1–9
Desoti VC, Lazarin-Bidóia D, Martins-Ribeiro F, Martins SC, Rodrigues JHS, Ueda-Nakamura T et al (2015) The combination of vitamin K3 and vitamin C has synergic activity against forms of Trypanosoma cruzi through a redox imbalance process. PLoS One 10:1–23
Duszenko M, Figarella K, Macleod ET, Welburn SC (2006) Death of a trypanosome: a selfish altruism. Trends Parasitol 22:536–542
El Mansari M, Blier P (2006) Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 30:362–373
Field MC, Carrington M (2009) The trypanosome flagellar pocket. Nat Rev Microbiol 7:775–786
Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson S, Abrams JM, Adam D et al (2015) Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ 22:58–73
Georgiadou SP, Makaritsis KP, Dalekos GN (2015) Leishmaniasis revisited: current aspects on epidemiology, diagnosis and treatment. J Transl Int Med 3:43–50
Hammond DJ, Cover B, Gutteridge WE (1984) A novel series of chemical structures active in vitro against trypomastigote form of Trypanosoma cruzi. Trans R Soc Trop Med Hyg 78:91–95
Hicks SW, Machamer CE (2005) Golgi structure in stress sensing and apoptosis. Biochim Biophys Acta 1744:406–414
Higgins SC, Pilkington GJ (2010) The in vitro effects of tricyclic drugs and dexamethasone on cellular respiration of malignant glioma. Anticancer Res 398:391–397
Holzmuller P, Bras-Gonçalves R, Lemesre J (2006) Phenotypical characteristics, biochemical pathways, molecular targets and putative role of nitric oxide-mediated programmed cell death in Leishmania. Parasitology 132:19–32
Kaiser M, Mäser P, Tadoori LP, Loset JR, Brun R (2015) Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning. PLoS One 10:1–16
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G et al (2016) Guidelines for use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12:1–222
Lazarin-Bidóia D, Desoti VC, Ueda-Nakamura T, Dias Filho BP, Nakamura CV, Silva SO (2013) Further evidence of the trypanocidal action of eupomatenoid-5: confirmation of involvement of reactive oxygen species and mitochondria owing to a reduction in trypanothione reductase activity. Free Radic Biol Med 60:17–28
Lorente SO, Rodrigues JCF, Jime C, Joyce-menekse M, Rodrigues C, Croft SL et al (2004) Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis. Antimicrob Agents Chemother 48:2937–2950
Maag RS, Hicks SW, Machamer CE (2003) Death from within: apoptosis and the secretory pathway. Curr Opin Cell Biol 15:456–461
McConville MJ, Saunders EC, Kloehn J, Dagley MJ (2015) Leishmania carbon metabolism in the macrophage phagolysosome-feast or famine? F1000Research 4:1–11
Menna-Barreto RFS, de Castro SL (2014) The double-edged sword in pathogenic trypanosomatids: the pivotal role of mitochondria in oxidative stress and bioenergetics. Biomed Res Int 2014:1–14
Menna-Barreto RFS, Corrêa JR, Cascabulho CM, Fernandes MC, Pinto V, Soares MJ et al (2009) Naphthoimidazoles promote different death phenotypes in Trypanosoma cruzi. Parasitology 136:499–510
Moradin N, Descoteaux A, Beverley SM (2012) Leishmania promastigotes: building a safe niche within macrophages. Front Cell Infect Microbiol 2:1–7
Mukherjee S, Mukherjee B, Mukhopadhyay R, Naskar K, Sundar S, Dujardin JC et al (2012) Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection. PLoS Negl Trop Dis 6:1–15
Munos B (2009) Lessons from 60 years of pharmaceutical innovation. Nat Rev Drug Discov 8:959–968
Okuno D, Lino R, Noji H (2011) Rotation and structure of FoF1-ATP synthase. J Biochem 149:655–664
Pace D (2014) Leishmaniasis. J Inf Secur 69:10–18
Padhy B, Gupta Y (2011) Drug repositioning: re-investigating existing drugs for new therapeutic indications. J Postgrad Med 57:153–160
Proto WR, Coombs GH, Mottram JC (2012) Cell death in parasitic protozoa: regulated or incidental? Nat Rev Microbiol 11:58–66
Rivarola HW, Bustamante JM, Presti SL, Fernández AR, Enders JE, Gea S et al (2005) Trypanosoma cruzi: chemotherapeutic effects of clomipramine in mice infected with an isolate obtained from an endemic area. Exp Parasitol 111:80–86
Rodrigues JHS, Stein J, Strauss M, Rivarola HW, Ueda-Nakamura T, Nakamura CV, Duszenko M (2016) Clomipramine kills Trypanosoma brucei by apoptosis. Int J Med Microbiol 306:196–205
Rosenzweig D, Smith D, Opperdoes F, Stern S, Olafson RW, Zilberstein D (2007) Retooling Leishmania metabolism: from sand fly gut to human macrophage. FASEB J 22:590–602
`Safiulina D, Veksler V, Zharkovsky A, Kaasik A (2006) Loss of mitochondrial membrane potential is associated with increase in mitochondrial volume: physiological role in neurones. J Cell Physiol 206:347–353
Smirlis D, Duszenko M, Ruiz A, Scoulica E, Bastien P, Fasel N, Soteriadou K (2010) Targeting essential pathways in trypanosomatids gives insights into protozoan mechanisms of cell death. Parasit Vectors 3:107–132
Takahashi M, Shibata M, Niki E (2001) Estimation of lipid peroxidation of live cells using a fluorescent probe, diphenyl-1-pyrenylphosphine. Free Radic Biol Med 31(2):164–174
Walter P, Ron D (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Science 334:1081–1086
WHO (2018) Leishmaniasis. World Health Organization. http://www.who.int/mediacentre/factsheets/fs375/en/. Accessed 06 July 2018
Zilberstein D, Dwyer DM (1984) Antidepressants cause lethal disruption of membrane function in the human protozoan parasite Leishmania. Science 226:977–979
Acknowledgments
We thank all the staffs of the “Laboratório de Inovação Tecnológica no Desenvolvimento de Fármacos e Cosméticos” and the “Complexo de Centrais de Apoio à Pesquisa (COMCAP-UEM)”.
Funding
This study was supported by grants of Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Capes), Financiadora de Estudos e Projetos (FINEP) and Programa de Núcleos de Excelência (PRONEX/Fundação Araucária).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Section Editor: Sarah Hendrickx
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
da Silva Rodrigues, J.H., Miranda, N., Volpato, H. et al. The antidepressant clomipramine induces programmed cell death in Leishmania amazonensis through a mitochondrial pathway. Parasitol Res 118, 977–989 (2019). https://doi.org/10.1007/s00436-018-06200-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-018-06200-x